Recurrent drug shortages signal onerous outlook for cardiovascular care
Pharmaceutical Technology
NOVEMBER 3, 2022
There, Boehringer had earlier warned of the impending alteplase shortage in April 2022. Second, adopting a single sourcing strategy creates more risk, explains Liz Breen, PhD, professor at the University of Bradford’s School of Pharmacy and Medical Sciences. Also, substitution can lead to further shortages, he adds.
111 
Let's personalize your content